Results 21 to 30 of about 448,309 (307)
Some epidemiological data about Stomach Cancer in Kosovo.
Albanian Journal of Trauma and Emergency Surgery, 2021 Despite the continuing decline in incidence, stomach cancer remains one of the most common and deadly neoplasms in the world [1]. According to the literature, stomach cancer is the third leading cause of cancer deaths worldwide, ranking third after lung ...
Imri Vishi, Agron Dogjani, Hysni Bendo
doaj +1 more source
Epidemiology of stomach cancer
World Journal of Gastroenterology, 2022 Despite a decline in incidence and mortality during the last decades, stomach cancer is one of the main health challenges worldwide. According to the GLOBOCAN 2020 estimates, stomach cancer caused approximately 800000 deaths (accounting for 7.7% of all cancer deaths), and ranks as the fourth leading cause of cancer deaths in both genders combined ...
Ilic, Milena, Ilic, Irena
openaire +2 more sources
BMC Cancer, 2010 Background Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is a powerful method for the analysis of gene expression. Target gene expression levels are usually normalized to a consistently expressed reference gene also ...
Lee Yeon-Su +5 more
doaj +1 more source
Acta Chimica Slovenica, 2023 Men with diabetes have a higher risk of prostate cancer and people with prostate cancer are prone to stomach metastases. Therefore, researchers are continuing in order to find new approaches in the treatment of individuals with both diseases at the same
Onur Ertik +3 more
doaj +1 more source
Estimating Time-Varying Effects of Prognostic Factors for Stomach Cancer Patients within a Dynamic Grouped Cox Model [PDF]
, 1996 We describe the identification of prognostic factors in the framework of a completely resected stomach cancer survival-study. For the analysis the dynamic grouped Cox-Model was used allowing for time-varying covariate effects.
Nekarda, H. +2 more
core +1 more source
Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer
Experimental and Molecular Medicine, 2019 Stomach cancer: identifying the right target Inhibiting histone deacetylase 9 (HDAC9), a protein that regulates gene expression, reduces stomach cancer cell growth. The efficacy of current treatments for stomach cancer is limited.
Kai Xiong +4 more
doaj +1 more source
BMC Cancer, 2017 Background Lung cancer survivors are more likely to develop colorectal and stomach cancer than the general population. However, little is known about the current status of gastrointestinal cancer screening practices and related factors among lung cancer ...
Sang Min Park +7 more
doaj +1 more source
FOXM1 coming of age: time for translation into clinical benefits? [PDF]
, 2012 A decade since the first evidence implicating the cell cycle transcription factor Forkhead Box M1 (FOXM1) in human tumorigenesis, a slew of subsequent studies revealed an oncogenic role of FOXM1 in the majority of human cancers including oral ...
Teh, M-T
core +1 more source
HeliyonA 55-year-old woman with non-small cell lung carcinoma complained of epigastric pain, bloating, anorexia and postprandial nausea and vomiting over a five-year period.
Xu Zhang +7 more
doaj +1 more source
Risk of stomach cancer in Aotearoa/New Zealand: A Māori population based case-control study. [PDF]
PLoS ONE, 2017 Māori, the indigenous people of New Zealand, experience disproportionate rates of stomach cancer, compared to non-Māori. The overall aim of the study was to better understand the reasons for the considerable excess of stomach cancer in Māori and to ...
Lis Ellison-Loschmann +9 more
doaj +1 more source